BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7241794)

  • 1. Phlebitis associated with the intravenous use of cephapirin and cephalothin in the combination therapy of antibiotics.
    Meguro S; Kuraishi Y; Kobayashi T; Chinen T; Ikeda K; Nagata T; Ichiba K; Abe M
    Jpn J Antibiot; 1980 Nov; 33(11):1163-5. PubMed ID: 7241794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phlebitis associated with the intravenous use of cephalothin and cephapirin.
    Sorrentino AP; Haughey EJ; Cronin DW; Bohen LN
    Am J Hosp Pharm; 1976 Jul; 33(7):642-4. PubMed ID: 941915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative incidence of phlebitis caused by continuous intravenous infusion of cephapirin and cephalothin.
    Lane AZ; Taggart JG; Iles RL
    Antimicrob Agents Chemother; 1972 Sep; 2(3):234-5. PubMed ID: 4790563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of side effects of intravenous cephapirin and cephalothin with special reference to the incidence of phlebitis].
    Watanabe A; Oizumi K; Konno K
    Jpn J Antibiot; 1983 Dec; 36(12):3395-8. PubMed ID: 6674550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative incidence of phlebitis due to buffered cephalothin, cephapirin, and cefamandole.
    Berger S; Ernst EC; Barza M
    Antimicrob Agents Chemother; 1976 Apr; 9(4):575-9. PubMed ID: 5053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phlebitis associated with cephalosporins: cephapirin versus cephalothin.
    Inagaki J; Bodey GP
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):37-43. PubMed ID: 4632504
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of thrombophlebitis associated with three cephalosporin antibiotics.
    Siebert WT; Westerman EL; Smilack JD; Bradshaw MW; Williams TW
    Antimicrob Agents Chemother; 1976 Sep; 10(3):467-9. PubMed ID: 791101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use, misuse, and cost of parenteral cephalosporins at a county hospital.
    Appleby DH; John JF
    South Med J; 1980 Nov; 73(11):1473-5. PubMed ID: 7444511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of phlebitis produced by cephapirin and cephalothin.
    Cross AS; Tramont EC
    Antimicrob Agents Chemother; 1976 Apr; 9(4):722-4. PubMed ID: 1267443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind comparison of phlebitis associated with cefazolin and cephalothin.
    Cole DR
    Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):75-7. PubMed ID: 789268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetic studies of cephapirin and cephalothin following intravenous and intramuscular administration.
    Lane AZ; Chudzik GM; Siskin SB
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):117-27. PubMed ID: 401706
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind controlled comparison of phlebitis produced by cephapirin and cephalothin.
    Carrizosa J; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1973 Feb; 3(2):306-7. PubMed ID: 4597719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing.
    Barza M; Melethil S; Berger S; Ernst EC
    Antimicrob Agents Chemother; 1976 Sep; 10(3):421-5. PubMed ID: 984783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind study to investigate methods to prevent cephalothin-induced phlebitis.
    Maddox RR; Rush DR; Rapp RP; Foster TS; Mazella V; McKean HE
    Am J Hosp Pharm; 1977 Jan; 34(1):29-34. PubMed ID: 831472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience in combination therapy with amikacin and cephapirin for infections complicated with acute leukemia during induction chemotherapy].
    Hasegawa S; Nakao I
    Jpn J Antibiot; 1984 Sep; 37(9):1631-6. PubMed ID: 6512982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empiric therapy for infections in granulocytopenic cancer patients: continuous infusion of amikacin plus cephalothin.
    Feld R; Tuffnell PG; Curtis JE; Messner HA; Hasselback R
    Arch Intern Med; 1979 Mar; 139(3):310-4. PubMed ID: 426575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of absorption and excretion of cefazolin with cephalothin and cephapirin.
    Shimizu T
    Jpn J Antibiot; 1975 Aug; 28(4):542-8. PubMed ID: 1160145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the penetration characteristics of cephapirin and cephalothin into right atrial appendage, muscle, fat, and pericardial fluid of pediatric patients undergoing open-heart operation.
    Green ER; Subramanian S; Faden H; Quintiliani R; Nightingale CH
    Ann Thorac Surg; 1981 Feb; 31(2):155-60. PubMed ID: 7458486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and in vitro evaluation of cephapirin, a new cephalosporin antibiotic.
    Bran JL; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1972 Jan; 1(1):35-40. PubMed ID: 4596741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocytopenia in hospitalized patients. II. A prospective comparison of two antibiotic regimens in the empiric therapy of febrile patients.
    Gurwith M; Brunton JL; Lank B; Ronald AR; Harding GK; McCullough DW
    Am J Med; 1978 Jan; 64(1):127-32. PubMed ID: 623129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.